A proposed class action lawsuit was recently filed by the insured Medical
Mutual of Ohio against Eli Lilly & Co, Actavis Pharma, Abbott Laboratories,
and their subsidiaries. The 341-page lawsuit accuses the pharmaceutical
companies of inventing the medical condition, known as low testosterone,
and using deceptive marketing to build a billion dollar industry. The
insurer alleges that the pharmaceutical companies violated civil racketeering
laws, RICO statutes, and consumer protection laws in all 50 states. In
addition, they allege that these drug makers engaged in fraud and negligent
misrepresentation, which resulted in billions of dollars in unjustified
claims for health insurers.
According to the complaint, the pharmaceutical companies deliberately convinced
millions of men that they were suffering from a medical condition, known
as low testosterone. In fact, the majority of these men were suffering
from nothing more than the normal aging process. They then deliberately
misrepresented the safety and effectiveness of their drugs and continued
to promote off-label uses. The lawsuit claims that these pharmaceutical
companies deliberately concealed the negative side effects of their drugs,
including heart complications, and illegally paid physicians “kickbacks”.
Medical Mutual has claimed that these drug companies used deceptive marketing
campaigns and direct to consumer marketing campaigns that generated annual
sales of $2 billion in 2012, all while purposefully downplaying and ignoring
health hazards and risks.
Sadly, both insurers and patients have suffered because of the off-label
marketing of low testosterone drugs. Currently, low testosterone drugs are
ONLY approved for men who have been diagnosed with hypogonadism.
Just How Risky are Low Testosterone Drugs?
The FDA is investigating recent connections between the use of popular
low testosterone drugs, such as Androgel, Androderm, Testopel, and Testim.
A recent study published in
Plus One found that men under the age of 65 years old with a history of heart disease
were 3x more likely to suffer a heart attack when taking low testosterone
supplements. Men over the age of 65 were 2x more likely to suffer a heart
attack-even if they never had a history of heart disease.
In light of these recent findings, the FDA advisory panel is recommending
a more comprehensive study relating to heart attack and testosterone supplements.
When asked about the risks of testosterone supplementation, FDA panel
member John Teerlink replied,
” We have no evidence of any benefit for patients and we have questions
about clinical safety.”
National Dangerous Drug Lawyers
You have a right to seek justice if you or someone you love has sustained
a heart attack or cardiac complication after using a low testosterone
drug. Drug companies who routinely put profits before people should pay
for their negligence-and their unscrupulous behavior. To learn more about
your legal options or to schedule a free consultation call the
Philadelphia product liability lawyers at Golomb & Honik today at
1-800-355-3300 or 1-215-985-9177 or fill out our confidential
The national dangerous drug lawyers at Golomb & Honik have successfully
represented individuals in Philadelphia, Pennsylvania, New Jersey, and
throughout the United States.